Alnylam Pharmaceuticals Announces Transition of Chief Financial Officer
Go back to Alnylam Pharmaceuticals Announces Transition of Chief Financial Officer| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 237.10 +0.54 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $236.56 | 52 Week High | $109.10 | |||
| Open | $224.46 | 52 Week Low | $31.38 | |||
| Day High | $239.08 | P/E | N/A | |||
| Day Low | $223.61 | EPS | $-1.45 | |||
| Volume | 1,847,140 | |||||
| ShangPharma Corp. ADS (NYSE: SHP) | Delayed: 8.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.95 | 52 Week High | $26.30 | |||
| Open | $8.95 | 52 Week Low | $26.03 | |||
| Day High | $8.95 | P/E | N/A | |||
| Day Low | $8.95 | EPS | $0.00 | |||
| Volume | 1,942,335 | |||||
